These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 30387173)

  • 1. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
    Long X; Lin XJ
    J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
    Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
    Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
    Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
    Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
    Zhang X; Wan G; Mlotshwa S; Vance V; Berger FG; Chen H; Lu X
    Cancer Res; 2010 Sep; 70(18):7176-86. PubMed ID: 20668064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mathematical model of ATM/p53/NF- κB pathways points to the importance of the DDR switch-off mechanisms.
    Jonak K; Kurpas M; Szoltysek K; Janus P; Abramowicz A; Puszynski K
    BMC Syst Biol; 2016 Aug; 10(1):75. PubMed ID: 27526774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel assay for screening WIP1 phosphatase substrates in nuclear extracts.
    Storchova R; Burdova K; Palek M; Medema RH; Macurek L
    FEBS J; 2021 Oct; 288(20):6035-6051. PubMed ID: 33982878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung.
    Rahman M; Lovat F; Romano G; Calore F; Acunzo M; Bell EH; Nana-Sinkam P
    J Biol Chem; 2014 Sep; 289(38):26406-26416. PubMed ID: 25092292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase.
    Brazina J; Svadlenka J; Macurek L; Andera L; Hodny Z; Bartek J; Hanzlikova H
    Cell Cycle; 2015; 14(3):375-87. PubMed ID: 25659035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin.
    Tang Q; Yuan Q; Li H; Wang W; Xie G; Zhu K; Li D
    Biochem Biophys Res Commun; 2018 Mar; 497(3):827-834. PubMed ID: 29432736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
    Zhang Y; Duan G; Feng S
    Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway.
    Sun D; Yu M; Li Y; Xing H; Gao Y; Huang Z; Hao W; Lu K; Kong C; Shimozato O; Ozaki T; Zhu Y
    FEBS Open Bio; 2019 Mar; 9(3):478-489. PubMed ID: 30868056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.
    Zhou Y; Huang Z; Wu S; Zang X; Liu M; Shi J
    J Exp Clin Cancer Res; 2014 Jan; 33(1):12. PubMed ID: 24468065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
    Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
    Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
    Lin S; Yu L; Song X; Bi J; Jiang L; Wang Y; He M; Xiao Q; Sun M; Olopade OI; Zhao L; Wei M
    Cell Death Dis; 2019 Sep; 10(9):666. PubMed ID: 31511498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking miR-27a-3p sensitises Taxol resistant osteosarcoma cells through targeting Fbxw7.
    Lu B; Feng Z; Fan B; Shi Y
    Bull Cancer; 2021 Jun; 108(6):596-604. PubMed ID: 33863546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis.
    Yang YQ; Zheng YH; Zhang CT; Liang WW; Wang SY; Wang XD; Wang Y; Wang TH; Jiang HQ; Feng HL
    Neurobiol Dis; 2020 Feb; 134():104648. PubMed ID: 31676238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma.
    Gu Z; Zhou Y; Cao C; Wang X; Wu L; Ye Z
    Biomed Pharmacother; 2020 Sep; 129():110363. PubMed ID: 32563982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squalene Inhibits ATM-Dependent Signaling in γIR-Induced DNA Damage Response through Induction of Wip1 Phosphatase.
    Tatewaki N; Konishi T; Nakajima Y; Nishida M; Saito M; Eitsuka T; Sakamaki T; Ikekawa N; Nishida H
    PLoS One; 2016; 11(1):e0147570. PubMed ID: 26824362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.